This Educational Series focuses on first-line reimbursed treatment options for BRAF-mutant advanced melanoma. This review covers diagnosis and prognosis, current guidelines and treatments, and key clinical studies.
The review includes guiding commentary from Associate Professor Matteo Carlino, a Medical Oncologist at Westmead and Blacktown Hospitals and Clinical Associate Professor at The University of Sydney.
Please login below to download this issue (PDF)